Mynvax Overview

  • Founded
  • 2017
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Mynvax General Information

Description

Developer of novel drugs designed to be used in vaccines for influenza. The company's drugs specialize in the treatment of flu and infectious disease for the healthcare industry and medical professionals, enabling medical professionals to help in their patient's recovery.

Contact Information

Website
www.mynvax.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 399, 17th Main Road,36th Cross
  • 4th T Block, Jayanagar
  • Bangalore, Karnataka 560041
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mynvax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 22-Feb-2022 00.000 Completed Out of Business
5. Early Stage VC (Series A) 19-Jul-2021 00.000 00.000 000.00 Completed Generating Revenue
4. Early Stage VC 08-Jul-2020 00.000 00.000 00.00 Completed Generating Revenue
3. Early Stage VC 30-Oct-2019 00000 00000 00.000 Completed Startup
2. Equity Crowdfunding Completed Startup
1. Accelerator/Incubator Completed Startup
To view Mynvax’s complete valuation and funding history, request access »

Mynvax Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferance Shares 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary Shares 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary Shares 14,350 $0.134273 $131.64 $131.64 1x $131.64 15.18%
Ordinary Shares 667 $0.134273 $1.34 $1.34 1x $1.34 1.39%
To view Mynvax’s complete cap table history, request access »

Mynvax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel drugs designed to be used in vaccines for influenza. The company's drugs specialize in the treatment
Drug Discovery
Bangalore, India
00.000
00000000 00 00.000

00000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000000000000
Mainz, Germany
0000 As of 0000
00.000
00000000 00.000

000000 0

llum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Hyderabad, India
0000 As of 0000
000
00.00 0000-00-00
00000000000 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mynvax Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioNTech Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
000000 0000000 Private Equity-Backed Hyderabad, India 0000 000 00000000000 000
You’re viewing 2 of 2 competitors. Get the full list »

Ready to get started?

Request a free trial